Get started
Work

A pathway toward clinical translation of hyperpolarized [1,4-13C2,2,3-d2]fumarate as an imaging biomarker for early cellular necrosis in vivo.

Year: 2024
Type: article
Abstract: Publication status: Published
Authors: Birchall, Jonathan R, Wodtke, Pascal, Grimmer, Ashley, Hansen, Esben SS, Bertelsen, Lotte B, Bøgh, Nikolaj, Wylot, Marta, Zamora-Morales, Maria J, Arponen, Otso, Horvat-Menih, Ines, Latimer, Elizabeth C, Tan, Fung, Pappa, Evita, Graggaber, Johann, Cheriyan, Joseph, Holmes, Kelly, Locke, Matthew J, Sladen, Helen, Boren, Joan, Kettunen, Mikko I, Chhabra, Anita, Wilkinson, Ian B, Laustsen, Christoffer, Brindle, Kevin, McLean, Mary A, Gallagher, Ferdia A
Institutions: University of Cambridge, Cancer Research UK Cambridge Center, Aarhus University, University of Eastern Finland, Cambridge University Hospitals NHS Foundation Trust, Cambridge Clinical Trials Unit, AstraZeneca (United Kingdom), Cancer Research UK
Language: English
Subfield: Spectroscopy
Field: Chemistry
Open Access status: green
Funders: Wellcome Trust, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, Cambridge Trust, Gates Cambridge Trust, NIHR Cambridge Biomedical Research Centre
Awards: G139696651, G1690597291, G2493601830, G2537968379, G370598735, G7826725679
OpenAlex ID: W7077981466
FWCI:
Cites:
Cited by:
Related to: